🔎 Trials Near Me

Home › Narcolepsy › Florida › Miami

Narcolepsy clinical trials in Miami, FL

7 studies for Narcolepsy are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

RecruitingPhase 2/3
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • and 1 more
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

RecruitingPhase 3
  • Alkermes Investigational Site, Miami
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

RecruitingPhase 3
  • PharmaDev Clinical Research Institute, LLC, Miami
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

RecruitingPhase 2/3
  • Alkermes Investigational Site, Miami
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

RecruitingPhase 2
  • Takeda Site 14, Miami
Ages 18 to 70 · All sexes · Updated Jun 29, 2026 · NCT07633301

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

RecruitingPhase 2
  • Vitaly Clinical Research LLC, Miami
  • Anchor Medical Research LLC, Miami
  • New Access Research & Medical Services Inc - Kendall, Miami
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07493265

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

RecruitingPhase 2
  • Miami, Florida, Miami
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674

Narcolepsy trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.